Pfizer Inc. Financial Ratios — PFE US Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	22.28	28.75	35.24	12.79	9.59	9.97	26.97	12.69	17.03	9.69	22.57	27.28	1.73	6.8	6.69
Return on Assets (%)	5.23	7.8	12.3	5.38	4.16	4.26	12.41	6.73	9.8	5.69	13.09	16.57	1	3.65	3.69
Return on Capital (%)	12.8	17.64	23	9.34	7.15	7.33	- -	- -	12.45	7.53	17.1	21.47	- -	- -	- -
Return on Invested Capital (%)	9	11.32	10.19	9.07	9.57	11.67	- -	- -	6.29	8.3	20.13	27.89	- -	- -	- -
Gross Margin (%)	79.52	82.03	81.42	80.69	80.25	76.67	78.63	77.99	80.31	79.63	62.08	66.05	58.1	71.94	74.33
EBITDA Margin (%)	42.33	45.24	44.15	38.38	37.12	36.85	38.71	31.55	31.94	34.08	35.55	42.68	17.98	34.5	38.35
Operating Margin (%)	27.54	31.24	31.73	27.21	26.56	25.95	26.78	16.48	17.87	22.84	29.16	37.67	7.42	23.48	27.82
Incremental Operating Margin (%)	-6.08	-4.17	23.04	144.87	69.36	18.47	-130.58	62.65	726.25	295.17	35.8	72.47	80.97	258.31	-235.59
Pretax Margin (%)	18.81	20.57	30.47	24.67	18.35	15.81	23.42	8.8	27.68	16.89	29.91	34.33	1.78	12.61	12.02
Profit Margin (%)	16.4	26.66	42.65	18.42	14.25	13.66	40.55	27.32	39.18	21.99	27.04	31.01	3.56	12.62	12.42
Net Income to Common Margin (%)	16.4	26.65	42.65	18.41	14.25	13.66	40.55	27.32	39.18	21.99	27.04	31.01	3.56	12.62	12.42
Effective Tax Rate (%)	31.54	19.76	27.4	25.49	22.2	13.45	- -	- -	5.15	5.26	7.62	9.58	- -	- -	- -
Dvd Payout Ratio (%)	78.91	72.2	57.31	72.22	99.13	100.79	35.79	204.75	74.7	125.93	38.79	28.58	418.23	117.69	124.82
Sustainable Growth Rate (%)	4.7	7.99	15.04	3.55	0.08	-0.08	17.32	-13.29	4.31	-2.51	13.82	19.48	-5.51	-1.2	-1.66

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	38,942	37,460	36,489	36,682	37,605	41,062	42,606	41,265	50,840	38,274	36,998	34,859	70,845	63,649	63,961
ST Debt	4,016	6,424	6,027	5,141	10,159	10,663	9,940	8,836	16,190	2,703	2,241	2,934	10,346	6,946	3,154
LT Debt	34,926	31,036	30,462	31,541	27,446	30,399	32,666	32,429	34,650	35,571	34,757	31,925	60,499	56,703	60,807
Total Debt/EBITDA	1.51	1.51	1.6	1.93	2.07	2.11	2.09	3.2	3.89	2.7	1.28	0.81	6.62	2.9	2.67
Net Debt/EBITDA	1.38	1.11	1.51	1.75	1.87	1.98	2.03	3.12	3.81	2.57	1.21	0.8	6.35	2.85	2.62
Total Debt/EBIT	2.32	2.19	2.23	2.72	2.9	3	3.03	6.13	6.95	4.02	1.56	0.91	16.04	4.26	3.67
Net Debt/EBIT	2.13	1.6	2.1	2.47	2.62	2.81	2.93	5.96	6.8	3.84	1.48	0.9	15.39	4.19	3.61
EBITDA to Interest Expense	15.37	16.25	16.11	14	15.12	16.41	16.02	9.79	8.31	9.8	22.38	34.88	4.85	7.1	8.99
EBITDA-CapEx/Interest Expense	14.25	15.32	15.07	12.83	13.88	14.73	14.27	8.16	6.74	7.89	20.28	32.27	3.08	6.16	8
EBIT to Interest Expense	10	11.22	11.57	9.93	10.82	11.56	11.08	5.11	4.65	6.57	18.36	30.79	2	4.83	6.52
Interest Expense	1,681	1,522	1,414	1,360	1,199	1,186	1,270	1,316	1,573	1,449	1,291	1,238	2,209	3,091	2,671
Common Equity/Total Assets	24.82	29.43	40.78	43.34	43.29	42.09	49.92	56.47	58.56	58.91	57.23	63.96	52.46	54.92	55.29
Long-Term Debt/Equity (%)	42.27	38	39.76	44.04	42.23	50.8	45.59	50.86	54.61	56.04	44.87	33.28	67.76	64.07	70.07
Long-Term Debt/Capital (%)	40.58	33.51	28.46	28.76	24.87	26.76	25.38	24.63	23.21	27.5	24.63	19.8	31.85	31.3	33.9
Long-Term Debt/Total Assets (%)	18.58	16.7	17.7	18.82	16.4	17.71	19.01	20.34	20.67	23.06	19.15	16.19	26.71	26.57	29.21
Total Debt/Equity (%)	47.13	45.86	47.62	51.22	57.86	68.62	59.46	64.72	80.13	60.3	47.76	36.34	79.34	71.92	73.71
Total Debt/Capital (%)	45.24	40.45	34.1	33.45	34.07	36.14	33.1	31.34	34.05	29.58	26.22	21.62	37.3	35.14	35.66
Total Debt/Total Assets (%)	20.71	20.16	21.2	21.89	22.47	23.93	24.8	25.88	30.34	24.82	20.39	17.68	31.28	29.83	30.73
Net Debt to Equity	43.28	33.52	44.77	46.55	52.25	64.28	57.59	62.93	78.36	57.49	45.25	35.91	76.15	70.74	72.39
Net Debt/Capital (%)	43.14	33.18	32.72	31.36	31.83	34.65	32.39	30.74	33.55	28.6	25.19	21.42	36.34	34.76	35.25
EBITDA	25,834	24,729	22,776	19,036	18,133	19,467	20,342	12,880	13,066	14,194	28,895	43,181	10,707	21,951	23,999
EBITDA-CapEx	23,952	23,310	21,311	17,453	16,637	17,468	18,125	10,744	10,602	11,429	26,184	39,945	6,800	19,042	21,370
Operating Income (Loss)	16,808	17,074	16,366	13,499	12,976	13,710	14,073	6,730	7,311	9,513	23,704	38,117	4,417	14,938	17,407

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.92	1.11	1.39	1.67	0.79	0.57	0.66	0.59	0.26	0.47	0.73	0.54	0.27	0.48	0.37
Current Ratio	2.1	2.22	2.41	2.58	1.49	1.25	1.35	1.57	0.88	1.35	1.4	1.22	0.91	1.17	1.16
Quick Ratio	1.69	1.48	1.79	2.18	1.16	0.94	1.03	0.95	0.51	0.9	1.1	0.88	0.59	0.82	0.8
CFO/Avg Current Liab	0.7	0.58	0.67	0.76	0.58	0.54	0.55	0.51	0.36	0.46	0.95	0.69	0.19	0.28	0.29
Common Equity/Total Assets	24.82	29.43	40.78	43.34	43.29	42.09	49.92	56.47	58.56	58.91	57.23	63.96	52.46	54.92	55.29
Long-Term Debt/Equity (%)	42.27	38	39.76	44.04	42.23	50.8	45.59	50.86	54.61	56.04	44.87	33.28	67.76	64.07	70.07
Long-Term Debt/Capital (%)	40.58	33.51	28.46	28.76	24.87	26.76	25.38	24.63	23.21	27.5	24.63	19.8	31.85	31.3	33.9
Long-Term Debt/Total Assets (%)	18.58	16.7	17.7	18.82	16.4	17.71	19.01	20.34	20.67	23.06	19.15	16.19	26.71	26.57	29.21
Total Debt/Equity (%)	47.13	45.86	47.62	51.22	57.86	68.62	59.46	64.72	80.13	60.3	47.76	36.34	79.34	71.92	73.71
Total Debt/Capital (%)	45.24	40.45	34.1	33.45	34.07	36.14	33.1	31.34	34.05	29.58	26.22	21.62	37.3	35.14	35.66
Total Debt/Total Assets (%)	20.71	20.16	21.2	21.89	22.47	23.93	24.8	25.88	30.34	24.82	20.39	17.68	31.28	29.83	30.73
CFO/Total Liabilities	19.21	16.08	18.52	17.81	14.35	14.49	16.78	16.54	12.09	15.87	31.32	28.89	6.34	10.2	9.64
CFO/CapEx	10.75	11.8	12.07	10.79	9.82	8.1	7.58	7.41	5.11	5.21	12.02	9.04	2.23	4.38	4.45
Altman's Z-Score	3.29	3.39	3.93	3.78	3.77	4.23	4.67	4.49	3.49	4.11	4.94	5.74	3.21	3.91	4.16

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.41	4.61	5.15	5.59	5.89	6.44	6.39	5.03	5.53	5.67	8.38	9.02	5.29	5.53	5.36
Days Sales Outstanding	82.74	79.24	70.87	65.33	61.93	56.66	57.12	72.62	66.02	64.34	43.54	40.46	69.01	66.05	68.06
Inventory Turnover	1.67	1.55	1.57	1.62	1.46	1.72	1.56	1.19	1.11	1.12	3.61	3.81	2.6	1.7	1.49
Days Inventory Outstanding	219.22	235.74	233.07	225.41	249.24	211.74	233.42	306.35	330.29	324.56	101.13	95.86	140.2	215.1	244.27
Accounts Payable Turnover	2.78	2.81	3.14	2.82	3.37	2.84	2.62	1.91	1.78	2.31	6.46	5.53	3.87	3	2.92
Accounts Payable Turnover Days	131.34	129.68	116.09	129.6	108.41	128.4	139.53	190.95	205.2	158.01	56.49	65.97	94.31	121.68	125.04
Cash Conversion Cycle	170.62	185.31	187.85	161.14	202.76	140	151.02	188.02	191.1	230.89	88.18	70.35	114.9	159.48	187.29
Inventory to Cash Days	-136.48	-156.49	-162.19	-160.08	-187.31	-155.07	-176.3	-233.73	-264.27	-260.21	-57.59	-55.4	-71.19	-149.05	-176.21
Inventories	6,610	6,076	6,166	5,663	7,513	6,783	7,578	7,508	7,068	8,020	9,059	8,981	10,189	10,851	10,654
Raw Materials	785	448	505	510	867	793	788	546	672	716	994	859	1,007	976	907
Work In Process	3,514	3,374	3,445	3,248	3,932	3,696	3,908	4,701	4,131	4,436	4,424	5,519	5,688	6,101	5,634
Finished Goods	2,311	2,254	2,216	1,905	2,714	2,293	2,883	2,262	2,265	2,867	3,641	2,603	3,495	3,775	4,113
Other Inventory	- -	- -	- -	- -	- -	1	-1	-1	- -	1	- -	- -	-1	-1	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	160,327	176,896	197,850	187,397	188,986	187,480	204,950	242,983	206,833	204,480	330,739	287,354	162,462	150,266	141,507
- Cash & Cash Equivalents	3,182	10,081	2,183	3,343	3,641	2,595	1,342	1,139	1,121	1,786	1,944	416	2,853	1,043	1,142
+ Preferred Equity and Hybrid Capital	45	39	33	29	26	24	21	19	17	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	431	418	313	321	278	296	348	351	303	235	262	256	274	294	299
+ Total Debt	38,942	37,460	36,489	36,682	37,605	41,062	42,606	41,265	50,840	38,274	36,998	34,859	70,845	63,649	63,961
Enterprise Value	173,293	182,414	202,277	188,307	203,605	211,012	227,933	265,785	248,347	230,766	336,930	299,737	220,891	193,732	192,171
Total Capital	86,073	92,605	107,020	109,663	110,361	113,617	128,730	131,656	149,298	129,371	141,127	161,247	189,950	181,148	179,351
Total Debt/Capital (%)	45.24	40.45	34.1	33.45	34.07	36.14	33.1	31.34	34.05	29.58	26.22	21.62	37.3	35.14	35.66
Total Debt / EV	0.22	0.21	0.18	0.19	0.18	0.19	0.19	0.16	0.2	0.17	0.11	0.12	0.32	0.33	0.33
EV/Sales	2.84	3.34	3.92	3.8	4.17	3.99	4.34	6.51	6.07	5.54	4.14	2.96	3.71	3.04	3.07
EV/EBITDA	6.71	7.38	8.88	9.89	11.23	10.84	11.21	20.64	19.01	16.26	11.66	6.94	20.63	8.83	8.01
EV/EBIT	10.31	10.68	12.36	13.95	15.69	15.39	16.2	39.49	33.97	24.26	14.21	7.86	50.01	12.97	11.04
EV/Cash Flow to Firm	8.1	10.15	10.81	10.41	13.03	12.25	11.99	15.42	17.64	14.63	9.98	9.86	16.69	12.23	13.28
EV/Free Cash Flow to Firm	7.45	9.41	10.03	9.57	11.89	10.98	10.74	13.72	15.01	12.45	9.24	8.91	12.88	10.33	11.24
Diluted Market Cap	161,414	178,465	200,231	189,701	191,464	189,636	207,971	247,328	210,770	207,314	337,057	293,759	164,362	151,221	142,254
Diluted Enterprise Value	197,650	206,301	234,883	223,390	225,732	228,423	249,604	287,824	260,808	244,037	372,373	328,458	232,628	214,121	205,372
EV per Share	22.17	24.51	29.69	29.67	32.97	34.65	38.18	45.26	44.59	41.54	60.16	53.45	39.14	34.2	33.82
TTM Sales	61,035	54,657	51,584	49,605	48,851	52,824	52,546	40,825	40,905	41,651	81,288	101,175	59,554	63,627	62,579
TTM EBITDA	25,834	24,729	22,776	19,036	18,133	19,467	20,342	12,880	13,066	14,194	28,895	43,181	10,707	21,951	23,999
TTM Operating Income	16,808	17,074	16,366	13,499	12,976	13,710	14,073	6,730	7,311	9,513	23,704	38,117	4,417	14,938	17,407
TTM Cash Flow to Firm	21,391	17,967	18,711	18,097	15,621	17,219	19,006	17,240	14,080	15,776	33,773	30,386	13,237	15,846	14,469
TTM Free Cash Flow to Firm	23,273	19,386	20,176	19,680	17,117	19,218	21,223	19,376	16,544	18,541	36,484	33,622	17,144	18,755	17,098

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	7.3	9.82	10.46	10.16	11.83	10.42	10.93	13.77	14	12.08	9.55	9.04	13.04	9.66	9.92
EV/EBIT	10.31	10.68	12.36	13.95	15.69	15.39	16.2	39.49	33.97	24.26	14.21	7.86	50.01	12.97	11.04
Enterprise Value	173,293	182,414	202,277	188,307	203,605	211,012	227,933	265,785	248,347	230,766	336,930	299,737	220,891	193,732	192,171
Low Price	15.76	19.67	24.01	26.08	26.99	26.78	29.29	31.47	32.2	26.43	33.36	41.45	25.76	24.48	20.92
EV/Sales	2.84	3.34	3.92	3.8	4.17	3.99	4.34	6.51	6.07	5.54	4.14	2.96	3.71	3.04	3.07
EV/EBITDA	6.71	7.38	8.88	9.89	11.23	10.84	11.21	20.64	19.01	16.26	11.66	6.94	20.63	8.83	8.01
Price/Earnings	16.02	12.14	8.99	20.52	27.16	25.99	9.62	21.79	12.91	22.33	15.05	9.16	76.67	18.71	18.21
Price/Earnings Average	14.46	11.23	8.51	19.96	28.35	26.26	9.05	19.54	13.16	21.19	10.74	8.91	98.25	19.67	18.16
Price/Earnings High	16.22	12.63	9.54	21.81	30.67	29.91	9.92	23.19	14.68	26.13	15.73	10.47	137.41	22.24	20.25
Price/Earnings Low	12.31	10.05	7.44	18.12	23.95	22.6	8.21	16.57	11.19	16.03	8.5	7.41	68.6	17.26	15.3
Price/Book Value	3.44	3.23	2.82	2.58	2.61	2.6	2.39	2.7	2.11	2.25	3.18	2.28	1.37	1.28	1.23
Price/Book Value Average	3.1	2.99	2.67	2.51	2.72	2.62	2.25	2.42	2.15	2.14	2.27	2.22	1.75	1.35	1.23
Price/Book Value High	3.48	3.37	2.99	2.74	2.95	2.99	2.47	2.87	2.4	2.63	3.33	2.6	2.45	1.52	1.37
Price/Book Value Low	2.64	2.68	2.33	2.28	2.3	2.26	2.04	2.05	1.83	1.62	1.8	1.84	1.22	1.18	1.03
Price/Tangible Book Value	-12.17	-24.68	-37.21	-33.21	-8	-3.97	-6.2	-9.77	-11.06	-14.18	106.42	245.39	-3.74	-4.24	-3.7
Price/Tangible Book Value Average	-10.98	-22.83	-35.2	-32.31	-8.35	-4.01	-5.83	-8.76	-11.27	-13.46	75.96	238.63	-4.8	-4.46	-3.69
Price/Tangible Book Value High	-12.32	-25.68	-39.48	-35.3	-9.03	-4.56	-6.39	-10.4	-12.57	-16.6	111.21	280.4	-6.71	-5.04	-4.12
Price/Tangible Book Value Low	-9.35	-20.42	-30.77	-29.33	-7.05	-3.45	-5.29	-7.43	-9.59	-10.18	60.12	198.51	-3.35	-3.91	-3.11
Price/Sales	2.63	3.24	3.84	3.78	3.87	3.55	3.9	5.95	5.06	4.91	4.07	2.84	2.73	2.36	2.26
Price/Sales Average	2.37	2.99	3.63	3.68	4.04	3.59	3.67	5.34	5.16	4.66	2.9	2.76	3.5	2.48	2.26
Price/Sales High	2.66	3.37	4.07	4.02	4.37	4.09	4.02	6.34	5.75	5.75	4.25	3.25	4.89	2.81	2.51
Price/Sales Low	2.02	2.68	3.17	3.34	3.41	3.09	3.33	4.53	4.38	3.52	2.3	2.3	2.44	2.18	1.9
Price/Cash Flow	7.92	10.56	11.19	10.97	12.87	11.58	12.2	15.35	16.43	14.2	10.15	9.82	18.67	11.79	12.09
Price/Cash Flow Average	7.15	9.77	10.58	10.67	13.43	11.7	11.48	13.77	16.75	13.47	7.25	9.55	23.93	12.4	12.06
Price/Cash Flow High	8.02	10.99	11.87	11.66	14.53	13.33	12.58	16.34	18.69	16.62	10.61	11.22	33.47	14.02	13.45
Price/Cash Flow Low	6.09	8.74	9.25	9.69	11.35	10.07	10.41	11.68	14.25	10.19	5.74	7.94	16.71	10.88	10.16
Price/Free Cash Flow Average	6.58	9.09	9.89	9.89	12.35	10.54	10.29	12.35	14.28	11.46	6.82	8.79	16.71	10.16	9.9
Price/Free Cash Flow High	7.39	10.22	11.09	10.8	13.36	12	11.28	14.66	15.93	14.13	9.98	10.33	23.37	11.49	11.04
Price/Free Cash Flow Low	5.61	8.13	8.65	8.98	10.43	9.07	9.33	10.47	12.14	8.67	5.4	7.31	11.67	8.91	8.34
EV/Sales Average	2.96	3.5	4.3	4.35	4.74	4.32	4.46	6.33	6.38	5.54	3.34	3.1	4.64	3.47	3.26
EV/Sales High	3.25	3.88	4.74	4.69	5.07	4.82	4.82	7.33	6.97	6.63	4.69	3.59	6.04	3.8	3.52
EV/Sales Low	2.61	3.19	3.84	4.02	4.11	3.82	4.12	5.52	5.61	4.41	2.73	2.64	3.59	3.17	2.91
EV/EBITDA Average	7	7.74	9.74	11.35	12.77	11.73	11.53	20.07	19.97	16.26	9.39	7.27	25.82	10.06	8.51
EV/EBITDA High	7.68	8.57	10.74	12.23	13.66	13.08	12.44	23.23	21.83	19.45	13.18	8.41	33.57	11	9.19
EV/EBITDA Low	6.17	7.05	8.7	10.46	11.08	10.37	10.64	17.49	17.55	12.93	7.69	6.19	19.95	9.18	7.58
EV/EBIT Average	10.76	11.22	13.55	16	17.85	16.65	16.66	38.4	35.69	24.26	11.45	8.24	62.59	14.79	11.74
EV/EBIT High	11.81	12.41	14.94	17.25	19.09	18.57	17.98	44.45	39.02	29.02	16.07	9.52	81.38	16.17	12.67
EV/EBIT Low	9.49	10.2	12.11	14.76	15.49	14.72	15.38	33.48	31.37	19.29	9.37	7.01	48.37	13.49	10.46
Last Price	20.51	23.77	29.04	29.53	30.6	30.79	34.33	41.38	37.14	36.81	59.05	51.24	28.79	26.53	24.9
High Price	20.76	24.73	30.81	31.39	34.56	35.44	35.41	44.05	42.24	43.08	61.71	58.55	51.6	31.54	27.69
Enterprise Value Average	180,927	191,486	221,806	216,004	231,581	228,260	234,469	258,454	260,939	230,768	271,401	314,132	276,455	220,909	204,272
Enterprise Value High	198,517	211,877	244,561	232,890	247,711	254,581	253,031	299,158	285,274	276,032	380,954	363,047	359,445	241,543	220,480
Enterprise Value Low	159,432	174,220	198,232	199,193	200,958	201,850	216,494	225,288	229,361	183,542	222,165	267,151	213,630	201,555	182,006

Shares Outstanding	7,575	7,276	6,399	6,291	6,175	6,070	5,979	5,717	5,534	5,567	5,620	5,616	5,646	5,667	5,686
Diluted Weighted Avg Shares	7,870	7,508	6,895	6,424	6,257	6,159	6,058	5,977	5,675	5,632	5,708	5,733	5,709	5,700	5,713
Basic Weighted Avg Shares	7,817	7,442	6,813	6,346	6,176	6,089	5,970	5,872	5,569	5,555	5,601	5,608	5,643	5,664	5,683
Revenue per Share	7.81	7.34	7.57	7.82	7.91	8.68	8.8	6.95	7.35	7.5	14.51	18.04	10.55	11.23	11.01
EBITDA per Share	3.3	3.32	3.34	3	2.94	3.2	3.41	2.19	2.35	2.56	5.16	7.7	1.9	3.88	4.22
Operating Income per Share	2.15	2.29	2.4	2.13	2.1	2.25	2.36	1.15	1.31	1.71	4.23	6.8	0.78	2.64	3.06
Basic EPS, GAAP	1.28	1.96	3.23	1.44	1.13	1.18	3.57	1.9	2.88	1.65	3.92	5.59	0.38	1.42	1.37
Basic EPS from Cont Ops	1.01	1.21	1.67	1.44	1.13	1.19	3.58	0.66	1.93	1.2	4.01	5.6	0.38	1.42	1.37
Diluted EPS, GAAP	1.27	1.94	3.19	1.42	1.11	1.17	3.52	1.87	2.82	1.63	3.85	5.47	0.37	1.41	1.36
Diluted EPS from Cont Ops	1	1.2	1.65	1.42	1.11	1.17	3.52	0.65	1.89	1.18	3.93	5.48	0.38	1.41	1.36
Dividend per Share	0.8	0.88	0.97	1.04	1.12	1.2	1.28	1.36	1.44	1.52	1.56	1.6	1.64	1.68	1.72
Cash Flow per Share	2.59	2.25	2.6	2.69	2.38	2.66	2.81	2.7	2.26	2.59	5.82	5.22	1.54	2.25	2.06
Free Cash Flow per Basic Share	2.35	2.06	2.38	2.44	2.14	2.33	2.44	2.33	1.82	2.1	5.33	4.64	0.85	1.74	1.6
Cash & Equivalents per Share	3.38	4.35	4.76	5.69	3.77	2.93	3.35	3.21	1.73	2.2	5.55	4.05	2.25	3.62	2.39
Book Value per Share	5.97	7.35	10.3	11.45	11.73	11.86	14.36	15.33	17.62	16.36	18.54	22.49	21.06	20.69	20.25
Tangible Book Value per Share	-1.69	-0.96	-0.78	-0.89	-3.83	-7.76	-5.54	-4.24	-3.36	-2.6	0.55	0.21	-7.69	-6.26	-6.73

Pfizer Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)